HUDDLE #TRENDS

The Battle to Lower U.S. Drug Prices: Who’s Winning?

Drug pricing continues to be a central issue in U.S. healthcare, affecting patients, providers, and the entire system.

In this week’s Huddle #Trends, I explore why drug prices remain so high, dive into who’s actually making progress in lowering them, and what the future might hold for affordable healthcare.

I break down the impact of policies like the Inflation Reduction Act and highlight innovative players like Cost Plus Drugs and Amazon Pharmacy. I also discuss the ongoing efforts by digital health platforms like Ro and how pharmaceutical companies like Eli Lilly are responding with their own strategies.

Upgrade to Huddle+ below to access the full report on drug pricing 👇️ 

Become a paying subscriber of Huddle+ to get access to this post and other subscriber-only content.

Already a paying subscriber? Sign In.

A subscription gets you:

• • Traditional Sunday Healthcare Huddle newsletter and...
• • Exclusive Content: Weekly Inefficiency Insights and Monthly Huddle #Trends newsletters
• • Huddle University: Courses on essential healthcare topics
• • The Huddle Community: Connect with a network of healthcare professionals, share insights, and stay ahead in the industry
• • Discount for physicians, trainees, providers, students, employers. Email [email protected]